Description

7-tert-Butyl 2-Methyl 5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate is a high-purity, advanced pharmaceutical intermediate belonging to the fused imidazopyrazine class of heterocyclic compounds. This compound is of significant value for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. Research and development teams in the global pharmaceutical and biotechnology sectors require this material for its precise chemical structure to facilitate efficient and scalable synthetic routes.

Application

• Pharmaceutical Intermediate: A key precursor in the research and development of new drug candidates, especially for central nervous system (CNS) and oncology targets.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes to develop novel therapeutic agents.
• Process Chemistry & Scale-Up: Serves as a defined starting material or intermediate for the pilot-scale and commercial-scale synthesis of active pharmaceutical ingredients (APIs).
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and development services for the pharmaceutical industry.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.

Basic Information

Product Name	7-tert-Butyl 2-Methyl 5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate
CAS No.	2101207-00-3
Molecular Formula	C14H21N3O4
Molecular Weight	295.34 g/mol
Synonyms	tert-Butyl 2-methyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate 2-carboxylate; 2-Methyl-5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylic acid 7-tert-butyl ester 2-methyl ester; 7-(tert-Butoxycarbonyl)-2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylic acid methyl ester; Methyl 7-(tert-butoxycarbonyl)-2-methyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine-2-carboxylate; CAS 2101207-00-3
EINECS	Contact for details

Quality Control

Our 7-tert-Butyl 2-Methyl 5,6-Dihydroimidazo[1,2-A]Pyrazine-2,7(8H)-Dicarboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect this moisture-sensitive material.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Identification (IR)	Conforms
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.